Non-A beta component of Alzheimer's disease amyloid (NAC) is amyloidogenic.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Biochemistry

• Publication date

  1995-08-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI00032A006PMID 7640267
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

  1995cited by this paper
• The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease?

  1995cited by this paper
• Transthyretin sequesters amyloid beta protein and prevents amyloid formation.

  1994cited by this paper
• Aluminum promotes the aggregation of Alzheimer's amyloid beta-protein in vitro.

  1994cited by this paper
• Synthetic post-translationally modified human A beta peptide exhibits a markedly increased tendency to form beta-pleated sheets in vitro.

  1994cited by this paper
• An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

  1994cited by this paper
• Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments.

  1994cited by this paper
• Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid beta protein analogues.

  1994cited by this paper
• Aluminum Promotes the Aggregation of Alzheimer′s Amyloid β-Protein in Vitro

  1994cited by this paper
• Synthetic post-translationally modified human Aβ peptide exhibits a markedly increased tendency to form β-pleated sheets in vitro

  1994cited by this paper
• Rapid induction of Alzheimer A beta amyloid formation by zinc.

  1994cited by this paper
• Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

  1993cited by this paper
• Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

  1993cited by this paper
• Amyloidogenicity of rodent and human βA4 sequences

  1993cited by this paper
• Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

  1993cited by this paper
• Amyloidogenicity of rodent and human beta A4 sequences.

  1993cited by this paper
• α1‐Antichymotrypsin Binding to Alzheimer Aβ Peptides Is Sequence Specific and Induces Fibril Disaggregation In Vitro

  1993cited by this paper
• The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.

  1993cited by this paper
• Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.

  1993cited by this paper
• Alpha 1-antichymotrypsin binding to Alzheimer A beta peptides is sequence specific and induces fibril disaggregation in vitro.

  1993cited by this paper
• Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.

  1993cited by this paper
• Amyloid β-peptide is produced by cultured cells during normal metabolism

  1992cited by this paper
• Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB.

  1992cited by this paper
• Mass spectrometry of purified amyloid beta protein in Alzheimer's disease.

  1992cited by this paper
• Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

  1992cited by this paper
• Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

  1992cited by this paper
• Predicted alpha-helical regions of the prion protein when synthesized as peptides form amyloid.

  1992cited by this paper
• Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.

  1992cited by this paper
• Amyloidosis in aging and Alzheimer's disease.

  1992cited by this paper
• Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production.

  1992cited by this paper
• Amyloid beta-peptide is produced by cultured cells during normal metabolism.

  1992cited by this paper
• Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

  1992cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

  1992cited by this paper
• The seminal role of beta-amyloid in the pathogenesis of Alzheimer disease.

  1992cited by this paper
• The Seminal Role of β‐Amyloid in the Pathogenesis of Alzheimer Disease

  1992cited by this paper
• Molecular biology of prion diseases

  1991cited by this paper
• Amyloid deposition as the central event in the aetiology of Alzheimer's disease.

  1991cited by this paper
• Amyloid in central nervous system disease.

  1990cited by this paper
• The human cystatin C gene (CST3), mutated in hereditary cystatin C amyloid angiopathy, is located on chromosome 20

  1989cited by this paper
• Human amyloidosis, Alzheimer disease and related disorders.

  1988cited by this paper
• Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease.

  1987cited by this paper
• Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.

  1987cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

  1984cited by this paper
• Immunogenic structure of the influenza virus hemagglutinin.

  1982cited by this paper
• A simple method for displaying the hydropathic character of a protein.

  1982cited by this paper
• Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts).

  1980cited by this paper
• Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).

  1980cited by this paper
• Empirical predictions of protein conformation.

  1978cited by this paper
• Prediction of chain turns in globular proteins on a hydrophobic basis

  1978cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• When Proteins Go MAD—Misfolded, Amplified, Detected: Advances in α-Synuclein Pathophysiology and RT-QuIC Detection

  2026cites this paper
• GABAergic neurons are a key cell type in a Drosophila model of PARK14/PLA2G6-associated neurodegeneration

  2025cites this paper
• The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson’s disease

  2024cites this paper
• Inhibition of fibril formation by polyphenols: molecular mechanisms, challenges, and prospective solutions.

  2024cites this paper
• An updated review on animal models to study attention-deficit hyperactivity disorder

  2024cites this paper
• Conformational dynamics of A30G α-synuclein that causes familial Parkinson disease

  2023cites this paper
• Are Gastrointestinal Microorganisms Involved in the Onset and Development of Amyloid Neurodegenerative Diseases?

  2023cites this paper
• Studies on alpha-synuclein and islet amyloid polypeptide interaction

  2023cites this paper
• Effect of bacteriophage-encoded chaperonins on amyloid transformation of α-synuclein.

  2022cites this paper
• The Neurodegenerative Elderly Syndrome (NES) hypothesis: Alzheimer and Parkinson are two faces of the same disease

  2022cites this paper
• A Microplate-Based Approach to Map Interactions between TDP-43 and α-Synuclein

  2022cites this paper
• Synthetic NAC 71-82 Peptides Designed to Produce Fibrils with Different Protofilament Interface Contacts

  2021cites this paper
• Engineering of a protein probe with multiple inputs and multiple outputs for evaluation of alpha synuclein aggregation states.

  2021cites this paper
• A Quantitative Perspective of Alpha-Synuclein Dynamics – Why Numbers Matter

  2021cites this paper
• Dimerization of α-Synuclein Fragments Studied by Isothermal-Isobaric Replica-Permutation Molecular Dynamics Simulation

  2021cites this paper
• The Scientific and Lay Narratives

  2020cites this paper
• Predictions for the 2020s and Beyond

  2020cites this paper
• Biomarkers: The Promise and the Fallacy

  2020cites this paper
• Symptomatic vs. Disease-Modifying Therapies

  2020cites this paper
• A Capped Peptide of the Aggregation Prone NAC 71–82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations

  2020cites this paper
• Our Living Dissonance

  2020cites this paper
• Scutellarin Inhibits the Uninduced and Metal-Induced Aggregation of ɑ-Synuclein and Disaggregates Preformed Fibrils: Implications for Parkinson's disease.

  2020cites this paper
• Index

  2020cites this paper
• Protein Paradox

  2020cites this paper
• Sequence and structure-based peptides as potent amyloid inhibitors: A review.

  2020cites this paper
• Brain Fables

  2020cites this paper
• The Non-Fibrillating N-Terminal of α-Synuclein Binds and Co-Fibrillates with Heparin

  2020cites this paper
• Preface 2 – Enter Patient

  2020cites this paper
• Protein Quality Control Pathways at the Crossroad of Synucleinopathies

  2020cites this paper
• The Fault in Our Models

  2020cites this paper
• The Moonshot: Population-Based Studies of Aging

  2020cites this paper
• References

  2020cites this paper
• Note Added at Press Time – Reviving LOF

  2020cites this paper
• Challenges Viewed from Afar

  2020cites this paper
• The Hypothesis That Refuses to Die

  2020cites this paper
• The Shaky Six and the “Second Reality”

  2020cites this paper
• Disease Subtypes: The Promise and the Fallacy

  2020cites this paper
• Disease “Redefinition”: A Tough Pill to Swallow

  2020cites this paper
• Preface 1 – The Question

  2020cites this paper
• Epilogue

  2020cites this paper
• Lessons from Oncology

  2020cites this paper
• Pieces of a Puzzle?

  2020cites this paper
• The role of lipids in α-synuclein misfolding and neurotoxicity

  2019cites this paper
• Disruptive membrane interactions of alpha-synuclein aggregates.

  2019cites this paper
• Dysfunction of Protein Homeostasis: Factors in uencing the Formation of alpha - Synuclein (Lewy Bodies) in Arabidopsis thaliana plants

  2019cites this paper
• N-Terminal Acetylation Affects α-Synuclein Fibril Polymorphism.

  2019cites this paper
• Alpha-Synuclein RNA Expression is Increased in Major Depression

  2019cites this paper
• Amyloid fibrils prepared using an acetylated and methyl amidated peptide model of the α-Synuclein NAC 71–82 amino acid stretch contain an additional cross-β structure also found in prion proteins

  2019cites this paper
• Segmental 13 C-Labeling and Raman Microspectroscopy of α-Synuclein Amyloid Formation.

  2018cites this paper
• Current Therapeutic Targets for Alzheimer's Disease

  2018cites this paper
• α-Synuclein and Polyunsaturated Fatty Acids: Molecular Basis of the Interaction and Implication in Neurodegeneration

  2018cites this paper
• Connecting chaperone-mediated autophagy dysfunction to cellular senescence.

  2018cites this paper
• The chaperonin CCT inhibits assembly of α-synuclein amyloid fibrils by a specific, conformation-dependent interaction

  2017cites this paper
• Parkinson’s Disease-associated proteins: studying their role in mitophagy with cellular and Drosophila models

  2017cites this paper
• Complexation of NAC-Derived Peptide Ligands with the C-Terminus of α-Synuclein Accelerates Its Aggregation.

  2017cites this paper
• Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy

  2017cites this paper
• The Oligomer Hypothesis in α-Synucleinopathy

  2017cites this paper
• Molecular Dynamics Study to Investigate the Dimeric Structure of the Full-Length α-Synuclein in Aqueous Solution

  2017cites this paper
• Analysis of sheep α-synuclein provides a molecular strategy for the reduction of fibrillation.

  2017cites this paper
• The inhibitory effects of biomimetically designed peptides on α-synuclein aggregation.

  2017cites this paper
• α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies

  2017cites this paper
• Self-Assembled Cyclic d,l-α-Peptides as Generic Conformational Inhibitors of the α-Synuclein Aggregation and Toxicity: In Vitro and Mechanistic Studies.

  2016cites this paper
• Cortical development & plasticity in the FMRP KO mouse

  2016cites this paper
• Development of biologics for use in translational medicine

  2015cites this paper
• Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models

  2014cites this paper
• Adult Hippocampal Neurogenesis in Parkinson's Disease: Impact on Neuronal Survival and Plasticity

  2014cites this paper
• Amyloid Polymorphism of α-Synuclein Induced by Active Firefly Luciferase

  2014cites this paper
• Early oligomerization stages for the non-amyloid component of α-synuclein amyloid.

  2014cites this paper
• α-Synuclein misfolding assessed with single molecule AFM force spectroscopy: effect of pathogenic mutations.

  2013cites this paper
• The role of α-synuclein in the pathophysiology of alcoholism.

  2013cites this paper
• A conformation-switching fluorescent protein probe for detection of alpha synuclein oligomers.

  2013cites this paper
• Biophysical characterization of α-synuclein and its controversial structure

  2013cites this paper
• Pathogenesis of neurodegenerative diseases via templated recruitment

  2013cites this paper
• Dopamine-Mediated Oxidation of Methionine 127 in α-Synuclein Causes Cytotoxicity and Oligomerization of α-Synuclein

  2013cites this paper
• Effects of Mutant Alpha-Synuclein In the Activation of Retrograde Fast Axonal Transport BY SUN

  2013cites this paper
• The dynamic structure of α-synuclein multimers.

  2013cites this paper
• Physiological factors could enhance amyloid-beta toxicity

  2013cites this paper
• Enteric alpha‐synuclein expression is increased in Parkinson's disease but not Alzheimer's disease

  2013cites this paper
• Effects of Mutant Alpha-Synuclein In the Activation of Retrograde Fast Axonal Transport

  2013cites this paper
• Metabolic Effects of a Stabilizing Peptide Fusion Protein of Leptin in Normal Mice

  2012cites this paper
• Manuscript in preparation : I . Aging in Rats Promotes Alzheimer ’ s Disease β-amyloid Aggregation and Toxicity by Metallostasis of Extraneuronal Zinc

  2012cites this paper
• Curcumin-glucoside, a novel synthetic derivative of curcumin, inhibits α-synuclein oligomer formation: relevance to Parkinson's disease.

  2012cites this paper
• Mimicking Phosphorylation at Serine 87 Inhibits the Aggregation of Human α-Synuclein and Protects against Its Toxicity in a Rat Model of Parkinson's Disease

  2012cites this paper
• Neuroproteases in Peptide Neurotransmission and Neurodegenerative Diseases

  2012cites this paper
• Regulation of α‐synuclein expression in down syndrome

  2012cites this paper
• Cytoprotective effect of chlorogenic acid against α-synuclein-related toxicity in catecholaminergic PC12 cells

  2012cites this paper
• Conserved core of amyloid fibrils of wild type and A30P mutant α‐synuclein

  2011cites this paper
• The role of the C‐terminus of human α‐synuclein: Intra‐disulfide bonds between the C‐terminus and other regions stabilize non‐fibrillar monomeric isomers

  2011cites this paper
• Contribution of Alanine-76 and Serine Phosphorylation in α-Synuclein Membrane Association and Aggregation in Yeasts

  2011cites this paper
• Intrinsically disordered proteins may escape unwanted interactions via functional misfolding.

  2011cites this paper
• A novel mechanism of non-Aβ component of Alzheimer's disease amyloid (NAC) neurotoxicity. Interplay between p53 protein and cyclin-dependent kinase 5 (Cdk5).

  2011cites this paper
• Creation of Aggregation‐Defective α‐Synuclein Variants by Engineering the Sequence Connecting β‐Strand‐Forming Domains

  2011cites this paper
• The role of α-synuclein in neurotransmission and synaptic plasticity.

  2011cites this paper
• NACP-Rep1 relates to Beck Depression Inventory Scores in Healthy Humans

  2011cites this paper
• Methionine oxidation stabilizes non-toxic oligomers of alpha-synuclein through strengthening the auto-inhibitory intra-molecular long-range interactions.

  2010influential citation
• Molecular interaction of α-synuclein with tubulin influences on the polymerization of microtubule in vitro and structure of microtubule in cells

  2010cites this paper
• Human β-Synuclein Rendered Fibrillogenic by Designed Mutations

  2010cites this paper
• Curvature dynamics of alpha-synuclein familial Parkinson disease mutants: molecular simulations of the micelle- and bilayer-bound forms.

  2009cites this paper
• Role of Synucleins in Alzheimer’s Disease

  2009influential citation
• Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation.

  2009cites this paper